"Netflix revised its Warner Bros. Discovery bid to $83 billion all-cash, ditching the cash-and-stock structure. The move simplifies shareholder approval and signals Netflix means business: no dilution, no complexity, just acquisition firepower. Co-CEO Ted Sarandos defended the deal, emphasizing the combined entity would increase content spending rather than cut it. Netflix stock is down 30% over six months, trading at $88 with an RSI of 27, deeply oversold. The all-cash structure removes valuation uncertainty and accelerates the timeline."
"Bristol Myers Squibb partnered with Microsoft to deploy AI-driven lung cancer detection using FDA-cleared algorithms. Microsoft's Precision Imaging Network identifies hard-to-detect lung nodules and connects patients to precision therapies. Microsoft trades at $460, down 5% year-to-date despite Q1 revenue of $77.7 billion (up 18% YoY). The stock's MACD shows bearish momentum accelerating, with the histogram widening to -2.08: technical weakness meeting fundamental strength."
Netflix revised its Warner Bros. Discovery bid to $83 billion in an all-cash offer, eliminating a cash-and-stock structure and simplifying shareholder approval. Co-CEO Ted Sarandos stated the combined company would increase content spending, not cut it. Netflix shares are down 30% over six months, trading at $88 with an RSI of 27, indicating deep oversold conditions and potential rebound. Bristol Myers Squibb partnered with Microsoft to deploy FDA-cleared AI for lung cancer detection via Microsoft's Precision Imaging Network. Microsoft trades at $460 with accelerating MACD bearish momentum, creating watch-for-entry opportunities amid expanding healthcare AI spending projected through 2026.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]